• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度私营部门抗生素消费的决定因素:使用 2011-2019 年横截面时间序列数据的准实验固定效应回归分析结果。

Determinants of private-sector antibiotic consumption in India: findings from a quasi-experimental fixed-effects regression analysis using cross-sectional time-series data, 2011-2019.

机构信息

School of Public Health, Boston University, Boston, MA, USA.

Public Health Foundation of India, New Delhi, Delhi, India.

出版信息

Sci Rep. 2024 Feb 29;14(1):5052. doi: 10.1038/s41598-024-54250-2.

DOI:10.1038/s41598-024-54250-2
PMID:38424115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10904839/
Abstract

The consumption of antibiotics varies between and within countries. However, our understanding of the key drivers of antibiotic consumption is largely limited to observational studies. Using Indian data that showed substantial differences between states and changes over years, we conducted a quasi-experimental fixed-effects regression study to examine the determinants of private-sector antibiotic consumption. Antibiotic consumption decreased by 10.2 antibiotic doses per 1000 persons per year for every ₹1000 (US$12.9) increase in per-capita gross domestic product. Antibiotic consumption decreased by 46.4 doses per 1000 population per year for every 1% increase in girls' enrollment rate in tertiary education. The biggest determinant of private sector antibiotic use was government spending on health-antibiotic use decreased by 461.4 doses per 1000 population per year for every US$12.9 increase in per-capita government health spending. Economic progress, social progress, and increased public investment in health can reduce private-sector antibiotic use.

摘要

抗生素的消费在国家之间和国家内部存在差异。然而,我们对抗生素消费的主要驱动因素的理解在很大程度上仅限于观察性研究。利用印度的数据,这些数据显示了各州之间的巨大差异和多年来的变化,我们进行了一项准实验固定效应回归研究,以研究私营部门抗生素消费的决定因素。人均国内生产总值每增加 1000 卢比(12.9 美元),抗生素消费就会减少 10.2 个抗生素剂量/每 1000 人/年。每增加 1%的高等教育女生入学率,抗生素消费就会减少 46.4 个剂量/每 1000 人/年。私人部门抗生素使用的最大决定因素是政府对卫生的支出-人均政府卫生支出每增加 12.9 美元,抗生素消费就会减少 461.4 个剂量/每 1000 人/年。经济进步、社会进步和增加公共卫生投资可以减少私营部门的抗生素使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/9badf4de66f7/41598_2024_54250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/87c3e8718478/41598_2024_54250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/41df3748dcdc/41598_2024_54250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/9badf4de66f7/41598_2024_54250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/87c3e8718478/41598_2024_54250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/41df3748dcdc/41598_2024_54250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb9/10904839/9badf4de66f7/41598_2024_54250_Fig3_HTML.jpg

相似文献

1
Determinants of private-sector antibiotic consumption in India: findings from a quasi-experimental fixed-effects regression analysis using cross-sectional time-series data, 2011-2019.印度私营部门抗生素消费的决定因素:使用 2011-2019 年横截面时间序列数据的准实验固定效应回归分析结果。
Sci Rep. 2024 Feb 29;14(1):5052. doi: 10.1038/s41598-024-54250-2.
2
Injectable antibiotic use in India: public-private share in volume and cost.印度注射用抗生素的使用情况:公私部门在用量和成本方面的占比
Wellcome Open Res. 2024 Feb 19;9:70. doi: 10.12688/wellcomeopenres.20633.1. eCollection 2024.
3
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.全球卫生融资的过去、现在和未来:对 195 个国家 1995 年至 2050 年用于卫生的发展援助、政府、自付费用和其他私人支出的评估。
Lancet. 2019 Jun 1;393(10187):2233-2260. doi: 10.1016/S0140-6736(19)30841-4. Epub 2019 Apr 25.
4
Are Air Pollution, Economic and Non-Economic Factors Associated with Per Capita Health Expenditures? Evidence from Emerging Economies.空气污染、经济和非经济因素与人均医疗支出有关吗?来自新兴经济体的证据。
Int J Environ Res Public Health. 2019 Jun 3;16(11):1967. doi: 10.3390/ijerph16111967.
5
Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data.印度的社区抗生素使用情况及其与欧洲国家的比较:来自药品销售数据的证据。
PLoS One. 2018 Oct 17;13(10):e0204805. doi: 10.1371/journal.pone.0204805. eCollection 2018.
6
Associations between private vaccine and antimicrobial consumption across Indian states, 2009-2017.2009-2017 年印度各邦私人疫苗和抗菌药物消费的关联。
Ann N Y Acad Sci. 2021 Jun;1494(1):31-43. doi: 10.1111/nyas.14571. Epub 2021 Feb 5.
7
Hong Kong domestic health spending: financial years 1989/90 to 2008/09.香港本地健康开支:1989/90 财政年度至 2008/09 财政年度。
Hong Kong Med J. 2012 Aug;18(4 Suppl 4):1-23.
8
Catastrophic health expenditure on private sector pharmaceuticals: a cross-sectional analysis from the state of Odisha, India.私营部门药品的灾难性卫生支出:来自印度奥里萨邦的横断面分析。
Health Policy Plan. 2022 Aug 3;37(7):872-884. doi: 10.1093/heapol/czac035.
9
Quantifying antibiotic use in typhoid fever in India: a cross-sectional analysis of private sector medical audit data, 2013-2015.量化印度伤寒中的抗生素使用情况:2013-2015 年私营部门医疗审计数据的横断面分析。
BMJ Open. 2022 Oct 17;12(10):e062401. doi: 10.1136/bmjopen-2022-062401.
10
The determinants of the public-private mix in Canadian health care expenditures: 1975-1996.1975 - 1996年加拿大医疗保健支出中公私混合的决定因素
Health Policy. 2000 Jun;52(2):87-112. doi: 10.1016/s0168-8510(00)00071-3.

本文引用的文献

1
Consumption of systemic antibiotics in India in 2019.2019年印度全身性抗生素的消费量。
Lancet Reg Health Southeast Asia. 2022 Jun 22;4:100025. doi: 10.1016/j.lansea.2022.100025. eCollection 2022 Sep.
2
Antibiotic consumption in India: geographical variations and temporal changes between 2011 and 2019.印度的抗生素消费情况:2011年至2019年间的地域差异和时间变化
JAC Antimicrob Resist. 2022 Oct 26;4(5):dlac112. doi: 10.1093/jacamr/dlac112. eCollection 2022 Oct.
3
Education level and misuse of antibiotics in the general population: a systematic review and dose-response meta-analysis.
教育水平与普通人群中抗生素的误用:系统评价和剂量反应荟萃分析。
Antimicrob Resist Infect Control. 2022 Feb 3;11(1):24. doi: 10.1186/s13756-022-01063-5.
4
Exploring gender differences in knowledge and practices related to antibiotic use in Southeast Asia: A scoping review.探索东南亚与抗生素使用相关的知识和实践中的性别差异:范围综述。
PLoS One. 2021 Oct 26;16(10):e0259069. doi: 10.1371/journal.pone.0259069. eCollection 2021.
5
Does the Economic Growth Improve Public Health? A Cross-Regional Heterogeneous Study in China.经济增长是否能改善公共健康?来自中国的跨区域异质研究。
Front Public Health. 2021 Jun 18;9:704155. doi: 10.3389/fpubh.2021.704155. eCollection 2021.
6
Investing preventive care and economic development in ageing societies: empirical evidences from OECD countries.在老龄化社会中投资预防性护理与经济发展:来自经合组织国家的实证证据
Health Econ Rev. 2021 Jun 4;11(1):18. doi: 10.1186/s13561-021-00321-3.
7
Climate change and antibiotic resistance: a deadly combination.气候变化与抗生素耐药性:致命组合。
Ther Adv Infect Dis. 2021 Feb 15;8:2049936121991374. doi: 10.1177/2049936121991374. eCollection 2021 Jan-Dec.
8
The role of vaccines in combatting antimicrobial resistance.疫苗在对抗抗微生物药物耐药性中的作用。
Nat Rev Microbiol. 2021 May;19(5):287-302. doi: 10.1038/s41579-020-00506-3. Epub 2021 Feb 4.
9
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.利用疫苗减少抗生素使用并预防抗生素耐药性:世界卫生组织行动框架。
Clin Infect Dis. 2021 Aug 16;73(4):e1011-e1017. doi: 10.1093/cid/ciab062.
10
Antimicrobial Resistance: Implications and Costs.抗菌药物耐药性:影响与成本
Infect Drug Resist. 2019 Dec 20;12:3903-3910. doi: 10.2147/IDR.S234610. eCollection 2019.